摘要
肌萎缩侧索硬化(amyotrophic lateral sclerosis,ALS)是一种尚无有效治疗方法的慢性进展性神经退行性疾病,其病因不明但与遗传、饮食、环境、生活习惯等许多因素有关。ALS发病机制包括谷氨酸兴奋性毒性、氧化应激、线粒体功能障碍和轴突运输破坏等。目前获批的ALS治疗药物有利鲁唑、依达拉奉,右美沙芬和奎尼丁组合以及Tofersen,处于临床研究期间的药物较多,有效治疗选择有限。本综述概括阐述了ALS的病因与发病机制,详细总结了ALS的中西医治疗方法,在临床实践中具有较大实用性。
Amyotrophic lateral sclerosis(ALS)is a chronic progressive neurodegenerative disease with no effective treatment.The etiology of ALS is unknown but it is related to many factors such as genetics,diet,environment,and lifestyle habits.The pathogenesis of ALS includes glutamate excitatory toxicity,oxidative stress,mitochondrial dysfunction,and axon transport disruption.Currently,the approved ALS treatment drugs include Riluzole,Edaravone,Dextromethorphan/Quinidine and Tofersen injection.There are many drugs in clinical trails,but effective treatment options are still limited.This review summarizes the etiology and pathogenesis of ALS,and summarizes in detail the traditional Chinese and Western medicine treatment methods for ALS,which has great practicability in clinical practice.
作者
VORATUNYAKIT Napattharin
SAEREETAVEEKUN Natkitta
韩小敬
李睿
张海涵
王呈蕙
潘卫东
VORATUNYAKIT Napattharin;SAEREETAVEEKUN Natkitta;HAN Xiaojing;LI Rui;ZHANG Haihan;WANG Chenghui;PAN Weidong(Department of Neurology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;First Department of Encephalopathy,Anhui Hospital Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Anhui Province,Hefei 230012,China;Encephalopathy Laboratory,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China)
出处
《神经病学与神经康复学杂志》
2024年第2期47-57,共11页
Journal of Neurology and Neurorehabilitation
基金
上海市浦东新区卫生健康委员会卫生行业专项(PW2022E-03)
关键词
肌萎缩侧索硬化
病因
发病机制
中西医结合
治疗进展
Amyotrophic lateral sclerosis
Etiology
Pathogenesis
Integrated Traditional Chinese and Western Medicine
Treatment progress